Tonix Pharmaceuticals Holding Corp Share Price Nasdaq
Equities
US8902604094
Pharmaceuticals
Sales 2024 * | 12.03M 947M | Sales 2025 * | 17.78M 1.4B | Capitalization | 18.84M 1.48B |
---|---|---|---|---|---|
Net income 2024 * | -79M -6.22B | Net income 2025 * | -91M -7.17B | EV / Sales 2024 * | 1.57 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.06 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.29
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |